AP
CELG

Atwood & Palmer’s Celgene Corp CELG Stock Holding History

Atwood & Palmer’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,120
Closed -$211K – 310
2019
Q3 		$211K Sell
2,120
-375
-15% -$35.6K 0.03% 120
2019
Q2 		$231K Sell
2,495
-84,024
-97% -$7.98M 0.03% 118
2019
Q1 		$8.16M Buy
86,519
+1,795
+2% +$157K 1.16% 31
2018
Q4 		$5.43M Sell
84,724
-1,552
-2% -$115K 0.86% 36
2018
Q3 		$7.72M Buy
86,276
+3,808
+5% +$337K 1.01% 31
2018
Q2 		$6.55M Sell
82,468
-69,883
-46% -$5.8M 0.9% 34
2018
Q1 		$13.6M Sell
152,351
-8,657
-5% -$831K 1.94% 17
2017
Q4 		$16.8M Sell
161,008
-2,691
-2% -$304K 2.36% 16
2017
Q3 		$23.9M Sell
163,699
-3,471
-2% -$473K 3.46% 7
2017
Q2 		$21.7M Buy
167,170
+5,920
+4% +$725K 3.41% 8
2017
Q1 		$20.1M Sell
161,250
-1,364
-0.8% -$163K 3.21% 10
2016
Q4 		$18.8M Buy
162,614
+6,721
+4% +$748K 3.39% 8
2016
Q3 		$16.3M Sell
155,893
-450
-0.3% -$48.7K 2.96% 12
2016
Q2 		$15.4M Buy
156,343
+2,543
+2% +$263K 2.79% 12
2016
Q1 		$15.4M Buy
153,800
+57,696
+60% +$5.94M 2.74% 12
2015
Q4 		$11.5M Buy
96,104
+6,847
+8% +$792K 2.18% 17
2015
Q3 		$9.65M Buy
89,257
+32,140
+56% +$3.99M 1.88% 22
2015
Q2 		$6.61M Buy
57,117
+545
+1% +$62.3K 1.19% 28
2015
Q1 		$6.52M Buy
56,572
+56,140
+12,995% +$6.71M 1.16% 30
2014
Q4 		$49K Buy
432
+100
+30% +$10.5K 0.01% 199
2014
Q3 		$31K Buy
+332
New +$30K 0.01% 230

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Atwood & Palmer's CELG Position: Q4 2019 in Review

Atwood & Palmer sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,120 shares — an estimated $211K sold.

Atwood & Palmer first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $23.9M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Atwood & Palmer reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Atwood & Palmer sold 2,120 Celgene Corp shares in Q4 2019, an estimated $211K.
  • Atwood & Palmer first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
  • Atwood & Palmer's Celgene Corp position peaked at $23.9M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Atwood & Palmer's 13F filing for Q4 2019, filed 5 Feb 2020.